ArticleJournal of medicinal chemistry2015

Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.

Ilaria Paterni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.